The UK’s Office of Fair Trading (OFT) has accused GlaxoSmithKline of paying generic manufacturers to delay the production of a generic equivalent of its antidepressant paroxetine, which it makes in Cork.

MORE than 180 anti-trust cases, 1,300 merger decisions, and 100 monitoring actions have been investigated by competition authorities in the EU food industry in seven years.